Table 2.
Parameter | No adverse reactions (n=113) | Adverse reactions (n=47) | t/χ2 | P |
---|---|---|---|---|
Tumor Lobe (Y/N) | 51 (45.13%)/62 (54.87%) | 23 (48.94%)/24 (51.06%) | 0.07 | 0.791 |
Bronchial Invasion (Y/N) | 35 (30.97%)/78 (69.03%) | 16 (34.04%)/31 (65.96%) | 0.037 | 0.847 |
Pleural Effusion (Y/N) | 15 (13.27%)/98 (86.73%) | 5 (10.64%)/42 (89.36%) | 0.039 | 0.844 |
Spiculation (Y/N) | 42 (37.17%)/71 (62.83%) | 16 (34.04%)/31 (65.96%) | 0.038 | 0.846 |